Skip to main content
. 2014 Dec 2;135(3):663–669.e12. doi: 10.1016/j.jaci.2014.10.020

Table E4.

ORs for reported outcomes at the time of sampling and with time lags associated with an hRV-positive breath sample

Outcome No lag
Lag of 3-4 d
Lag of 6-8 d
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Cough/phlegm 1.12 0.70 to 1.79 .62 1.65 0.92 to 2.98 .94 0.71 0.40 to 1.28 .26
Wheeze/chest tightness 0.79 0.43 to 1.44 .44 1.65 0.84 to 3.27 .15 1.61 0.83- to 3.12 .16
Reliever use 0.90 0.55 to 1.48 .67 1.15 0.63 to 2.13 .65 1.03 0.58 to 1.83 .92
Composite febrile 0.45 0.17 to 1.17 .11 1.84 0.75 to 4.51 .18 1.14 0.45 to 2.87 .78
Composite coryzal 0.75 0.44 to 1.29 .30 1.55 0.76 to 3.17 .23 1.21 0.61 to 2.39 .59
Difference
PEF z score −0.040 −0.22 to 0.14 .66 0.14 −0.080 to 0.35 .22 0.20 0.0097 to 0.40 .040
FEV1z score −0.0048 −0.18 to 0.17 .96 −0.04 −0.25 to 0.18 .75 0.22 0.03 to 0.42 .030

Only those samples recorded in the period of 3 and 4 days and the period of 6, 7, and 8 days after the initial sample were used in the analysis of lags.

OR, Odds ratio.

Values in boldface are P < .05.